Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & Rescheduling Efforts
Oklahoma Legislature advances bill to study effect of ‘shrooms’ on PTSD, depression
If passed, the Oklahoma bill would allow clinical trials on psychedelics in relation to depression, anxiety, opioid use disorder and dementia.
GOP Missouri Lawmaker Files Psychedelics Therapy And Decriminalization Bill
A Missouri Republican lawmaker filed a bill on Tuesday that would legalize a wide range of psychedelics for therapeutic use at designated care facilities while further decriminalizing low-level possession in general. The bill from Rep. Tony Lovasco (R) is one of the latest examples of psychedelics r…
Oregon Psilocybin Services Act
The Biggest Reason People in Oregon Want to Use Psilocybin
A new Oregon Health Authority survey finds most popular reason why people want a taste of psilocybin — and it’s not because they’re depressed.
Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care
/PRNewswire/ -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) (“Field Trip”), a global leader in the development and delivery of psychedelic-assisted...
It’s Time to Start Studying the Downside of Psychedelics
Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.
Dr. Bronner’s, the Soap Company, Dips Into Psychedelics
Under the leadership of the founder’s grandsons, the company has become a big financial backer of efforts to loosen government restrictions on illegal drugs.
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
Psychedelinks by Emerge Law Group